Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilent TechnologiesMEX:A 89 ROC (Joel Greenblatt) % is 57.10% as of Apr. 2026, which is 23% below its 10-year median of 74.58. GuruFocus rates MEX:A with a GF Score™ of 89/100 and a GF Value™ of MXN2,533.05 (Fairly Valued). The stock has 1 warning sign investors should review. Among 212 Medical Diagnostics & Research companies, Agilent Technologies ranks better than 89.15% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Agilent Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 57.10%.
The historical rank and industry rank for Agilent Technologies's ROC (Joel Greenblatt) % or its related term are showing as below:
MEX:A'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 52.4 Med: 74.58 Max: 99.79
Current: 60.54
During the past 13 years, Agilent Technologies's highest ROC (Joel Greenblatt) % was 99.79%. The lowest was 52.40%. And the median was 74.58%.
MEX:A's ROC (Joel Greenblatt) % is ranked better than 89.15% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.815
vs MEX:A: 60.54
Agilent Technologies's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -6.80% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Agilent Technologies ROC (Joel Greenblatt) % Related Terms
Agilent Technologies ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:A vs NTRA, WAT, IDXX: ROC (Joel Greenblatt) % Comparison
For the Diagnostics & Research subindustry, Agilent Technologies's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies ROC (Joel Greenblatt) % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 57.10% mean?
Agilent Technologies (MEX:A) has a ROC (Joel Greenblatt) % of 57.10% as of Apr. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Agilent Technologies and its competitors. This is 23% below median its historical median of 74.58. Over the past decade, Agilent Technologies' ROC (Joel Greenblatt) % has ranged from 52.40 to 99.79. According to the industry distribution chart, Agilent Technologies ranks #23 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 10.8%.
Is Agilent Technologies' ROC (Joel Greenblatt) % too high?
Agilent Technologies' current ROC (Joel Greenblatt) % of 57.10% is 23% below median its 10-year median of 74.58. Over the past 10 years, this metric has ranged from a low of 52.40 to a high of 99.79. Based on the distribution chart, Agilent Technologies ranks #23 out of 212 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Agilent Technologies has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' ROC (Joel Greenblatt) % compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #23 out of 212 companies for ROC (Joel Greenblatt) %. This places Agilent Technologies in the top 11% of its industry — outperforming the majority of peers. Historically, Agilent Technologies' own ROC (Joel Greenblatt) % has ranged from 52.40 to 99.79 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Diagnostics & Research company?
A good ROC (Joel Greenblatt) % depends on the Medical Diagnostics & Research industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Agilent Technologies and its competitors. Agilent Technologies's current ROC (Joel Greenblatt) % is 57.10%, which is 23% below median its own 10-year median of 74.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (MEX:A) is currently considered Fairly Valued. The stock's GF Value™ is MXN2,533.05, compared to a current price of MXN2,350.00 — trading 7.2% below its estimated fair value. The current ROC (Joel Greenblatt) % is 57.10%, which is 23% below median its 10-year median of 74.58. Agilent Technologies' overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Agilent Technologies (MEX:A), the current ROC (Joel Greenblatt) % is 57.10% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (MEX:A) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of MXN2,350.00 is trading 7.2% below its estimated GF Value™ of MXN2,533.05.
GuruFocus considers Agilent Technologies to be Fairly Valued.
Key valuation signals for MEX:A:
ROC (Joel Greenblatt) %: 57.10% (23% below median its 10-year median of 74.58)
GF Value™: MXN2,533.05 vs. price of MXN2,350.00 (7.2% below fair value)
No single metric tells the full story. See the MEX:A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
89GF Score
Get the complete analysis for MEX:A
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:A has been successfully added to your 
